Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats

European Journal of Pharmacology

Volumn 562, Issue 3, 2007, Pages 191-197

  Murray, Fraser ^a   Harrison, Neil J ^b   Grimwood, Sarah ^c   Bristow, Linda J ^d   Hutson, Peter H ^e  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c PFIZER INC   (United States)

^d ROCHE BIOSCIENCE   (United States)

^e NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Behaviour; Dopamine; MK 801; Morphine; NMDA; NR2A

Indexed keywords

ANTIBODY; DIZOCILPINE; DOPAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; RADIOLIGAND; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; FOREBRAIN; FRONTAL CORTEX; GENE EXPRESSION; GENE FUNCTION; HIPPOCAMPUS; HYPERACTIVITY; LIGAND BINDING; LIMBIC SYSTEM; MALE; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; DIZOCILPINE MALEATE; DOPAMINE; GENE EXPRESSION; HIPPOCAMPUS; HYPERKINESIS; LIMBIC SYSTEM; MALE; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; NARCOTICS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34247170735     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.027     Document Type: Article

References (27)

1. Bhargava H.N., Reddy P.L., and Gudehithlu K.P. Down-regulation of N-methyl-d-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine. Gen. Pharmacol. 26 (1995) 131-136
2. Bristow L.J., Hogg J.E., and Hutson P.H. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats. Neuropharmacology 36 (1997) 241-250
3. Carlsson M., and Svensson A. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Life Sci. 47 (1990) 1729-1736
4. French E.D., and Vantini G. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants. Psychopharmacology (Berl.) 82 (1984) 83-88
5. Goebel D.J., and Poosch M.S. NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A. Brain Res. Mol. Brain Res. 69 (1999) 164-170
6. Gonzalez P., Cabello P., Germany A., Norris B., and Contreras E. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. Eur. J. Pharmacol. 332 (1997) 257-262
7. Grimwood S., Le Bourdelles B., Atack J.R., Barton C., Cockett W., Cook S.M., Gilbert E., Hutson P.H., McKernan R.M., Myers J., Ragan C.I., Wingrove P.B., and Whiting P.J. Generation and characterisation of stable cell lines expressing recombinant human N-methyl-d-aspartate receptor subtypes. J. Neurochem. 66 (1996) 2239-2247
8. Harrison N.J., Murray F., Grimwood S., and Hutson P.H. Alterations of forebrain NMDA receptors in morphine dependent rats. Eur. J. Neurosci. 12 11 (2000) 98
9. Hutson P.H., Bristow L.J., Thorn L., and Tricklebank M.D. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmacol. 103 (1991) 2037-2044
10. Imperato A., Scrocco M.G., Bacchi S., and Angelucci L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187 (1990) 555-556
11. Inoue M., Mishina M., and Ueda H. Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J. Neurosci. 23 (2003) 6529-6536
12. Leone P., Pocock D., and Wise R.A. Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol. Biochem. Behav. 39 (1991) 469-472
13. Loscher W., and Honack D. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur. J. Pharmacol. 215 (1992) 199-208
14. Maldonado R., Negus S., and Koob G.F. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology 31 (1992) 1231-1241
15. Martin G., Guadano-Ferraz A., Morte B., Ahmed S., Koob G.F., De Lecea L., and Siggins G.R. Chronic morphine treatment alters N-methyl-d-aspartate receptors in freshly isolated neurons from nucleus accumbens. J. Pharmacol. Exp. Ther. 311 (2004) 265-273
16. Miyamoto Y., Yamada K., Nagai T., Mori H., Mishina M., Furukawa H., Noda Y., and Nabeshima T. Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit. Eur. J. Neurosci. 19 (2004) 151-158
17. Mohn A.R., Gainetdinov R.R., Caron M.G., and Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98 (1999) 427-436
18. Pina-Crespo J.C., and Gibb A.J. Subtypes of NMDA receptors in new-born rat hippocampal granule cells. J. Physiol. 541 (2002) 41-64
19. Popik P., Mamczarz J., Fraczek M., Widla M., Hesselink M., and Danysz W. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology 37 (1998) 1033-1042
20. Siggins G.R., Martin G., Roberto M., Nie Z., Madamba S., and De Lecea L. Glutamatergic Transmission in Opiate and Alcohol Dependence. Ann. N.Y. Acad. Sci. 1003 (2003) 196-211
21. Stephenson F.A. Subunit characterization of NMDA receptors. Curr. Drug Targets 2 (2001) 233-239
22. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., Liu G., and Tsien J.Z. Genetic enhancement of learning and memory in mice. Nature 401 (1999) 63-69
23. Tricklebank M.D., Singh L., Oles R.J., Preston C., and Iversen S.D. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167 (1989) 127-135
24. Trujillo K.A. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl.) 151 (2000) 121-141
25. Trujillo K.A., and Akil H. Inhibition of opiate tolerance by non-competitive N-methyl-d-aspartate receptor antagonists. Brain Res. 633 (1994) 178-188
26. Yamakura T., and Shimoji K. Subunit- and Site-Specific Pharmacology of the NMDA Receptor Channel. Prog. Neurobiol. 59 (1999) 279-298
27. Zhu H., Jang C.G., Ma T., Oh S., Rockhold R.W., and Ho I.K. Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment. Eur. J. Pharmacol. 365 (1999) 47-54